Conjugated linoleic acid synergizes with the CYP1B1 inhibitor 2,31,4,5'-tetramethoxystilbene in suppressing breast cancer cell growth.

被引：0
|
作者：
Kirma, N. B. [1 ]
Nair, H. B. [1 ]
Liu, Y-G [1 ]
Tekmal, R. R. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [1] Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients
    Ociepa-Zawal, Marta
    Rubis, Blazej
    Filas, Violetta
    Breborowicz, Jan
    Trzeciak, Wieslaw H.
    GINEKOLOGIA POLSKA, 2009, 80 (11) : 819 - 823
  • [2] CYP1B1*2 and CYP1B1*3 polymorphisms and clinical outcome in non-small cell lung cancer patients
    Iscan, Mumtaz
    Ada, Ahmet Oguz
    Guler, Asena
    Kunak, Celalettin Semih
    Gulhan, Meral
    TOXICOLOGY LETTERS, 2017, 280 : S239 - S239
  • [3] Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene
    Zaabalawi, Azziza
    Renshall, Lewis
    Beards, Frances
    Lightfoot, Adam P.
    Degens, Hans
    Alexander, Yvonne
    Hasan, Ragheb
    Bilal, Haris
    Graf, Brigitte A.
    Harris, Lynda K.
    Azzawi, May
    PHARMACEUTICS, 2022, 14 (10)
  • [4] 3,4,2′-Trimethoxy-trans-stilbene - a potent CYP1B1 inhibitor
    Mikstacka, Renata
    Wierzchowski, Marcin
    Dutkiewicz, Zbigniew
    Gielara-Korzanska, Agnieszka
    Korzanski, Artur
    Teubert, Anna
    Sobiak, Stanislaw
    Baer-Dubowska, Wanda
    MEDCHEMCOMM, 2014, 5 (04) : 496 - 501
  • [5] Modulation of CYP1A1, CYP1A2 and CYP1B1 Expression by Cabbage Juices and Indoles in Human Breast Cell Lines
    Szaefer, Hanna
    Licznerska, Barbara
    Krajka-Kuzniak, Violetta
    Bartoszek, Agnieszka
    Baer-Dubowska, Wanda
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2012, 64 (06): : 879 - 888
  • [6] POLYMORPHISMS IN CYP1A1, CYP1A2, CYP1B1, IL6R AND TNF IN RELATION TO BREAST CANCER SURVIVAL
    Andersen, S. W.
    Trentham-Dietz, A.
    Engelman, C. D.
    Skinner, H. G.
    Garcia-Closas, M.
    Titus-Ernstoff, L.
    Hampton, J. M.
    Newcomb, P. A.
    Egan, K. M.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 : S4 - S4
  • [7] CYP1A1, CYP1A2, and CYP1B1, and risk of breast cancer and fibrocystic breast conditions among women in a Chinese breast self-examination trial.
    Doherty, Jennifer A.
    Ray, Roberta
    Blackston, Christie
    Gao, Dao Li
    Stalsberg, Helge
    Feng, Ziding
    Thomas, David B.
    Chen, Chu
    CANCER RESEARCH, 2006, 66 (08)
  • [8] Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status
    Angus, WGR
    Larsen, MC
    Jefcoate, CR
    CARCINOGENESIS, 1999, 20 (06) : 947 - 955
  • [9] Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4′ hydroxy tangeretin
    Surichan, Somchaiya
    Arroo, Randolph R.
    Tsatsakis, Aristidis M.
    Androutsopoulos, Vasilis P.
    TOXICOLOGY IN VITRO, 2018, 50 : 274 - 284
  • [10] Human CYP1B1 activates uPA-uPAR-integrin pathway through suppressing p53 signaling in human breast cancer cell progression and metastasis
    Chun, Y. J.
    Kwon, Y. J.
    Shin, S.
    Baek, H. S.
    Ye, D. J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S137 - S137
12345